HBK INVESTMENTS L P
Institutional investor · Portfolio as of Q1 2019
Top Holdings1,019 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
ALTABA INC | 14.4M | $1.1B | 10.8% | — | — | 1 qtr | New 98 |
RED HAT INC | 4.8M | $877M | 8.9% | — | — | 1 qtr | New 98 |
FIRST DATA CORP NEW | 20M | $525.4M | 5.3% | — | — | 1 qtr | New 97 |
INTEGRATED DEVICE TECHNOLOGY INC | 6.4M | $313.6M | 3.2% | — | — | 1 qtr | New 86 |
CELGENE CORP | 3.3M | $312.7M | 3.2% | — | — | 1 qtr | New 86 |
BEMIS CO INC | 4.5M | $251.2M | 2.5% | $55.17 | — | 1 qtr | New 80 |
| 747,800 | $209.3M | 2.1% | — | — | — | New — | |
TRIBUNE MEDIA CO | 4.3M | $198.4M | 2.0% | — | — | 1 qtr | New 79 |
| 4.1M | $194.2M | 2.0% | — | — | — | New — | |
PETROLEO BRASIL-SP PREF ADR | 8.9M | $126.9M | 1.3% | $3.97 | 0.00% | 1 qtr | New 69 |
| 108.8M | $112M | 1.1% | — | — | 1 qtr | New 69 | |
| 500,000 | $89.8M | 0.9% | — | — | — | New — | |
WALT DISNEY CO/THE | 727,418 | $80.8M | 0.8% | $107.17 | 0.00% | 1 qtr | New 58 |
REX IncomeMax Option Strategy E | 200,200 | $66.1M | 0.7% | — | — | 1 qtr | New 58 |
| 500,000 | $64.4M | 0.7% | — | — | — | New — | |
EQT CORP | 3M | $62.2M | 0.6% | $19.07 | 0.00% | 1 qtr | New 58 |
AUTOMATIC DATA PROCESSING | 356,778 | $57M | 0.6% | $138.46 | 0.00% | 1 qtr | New 57 |
BOEING CO/THE | 149,257 | $56.9M | 0.6% | $372.49 | 0.00% | 1 qtr | New 57 |
ELANCO ANIMAL HEALTH INC | 1.7M | $55.8M | 0.6% | $32.07 | 0.00% | 1 qtr | New 57 |
TAKEDA PHARMACEUTIC-SP ADR | 2.6M | $53.8M | 0.5% | $19.07 | 0.00% | 1 qtr | New 57 |
HBK INVESTMENTS L P manages $9.9B across 1019 positions as of Q1 2019. Top holdings: AABA (10.8%), RHT (8.9%), FDC (5.3%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 2.5/5.0.
Active quarter - 812 new positions, 0 exits, 0 increased. Top move: AABA (NEW, conviction 98). Portfolio: $9.9B across 1019 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer